These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8115727)

  • 1. Five-year results of vitrectomy and silicone oil in patients with proliferative vitreoretinopathy.
    van Meurs JC; Mertens DA; Peperkamp E; Post J
    Retina; 1993; 13(4):285-9. PubMed ID: 8115727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of silicone oil removal. Silicone Study Report 6.
    Hutton WL; Azen SP; Blumenkranz MS; Lai MY; McCuen BW; Han DP; Flynn HW; Ramsay RC; Ryan SJ
    Arch Ophthalmol; 1994 Jun; 112(6):778-85. PubMed ID: 8002836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 1.
    Arch Ophthalmol; 1992 Jun; 110(6):770-9. PubMed ID: 1596224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of silicone oil removal from eyes treated with retinectomies.
    Eckardt C; Behrendt S; Zwick A
    Ger J Ophthalmol; 1992; 1(1):2-6. PubMed ID: 1477612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone Study report 11.
    Abrams GW; Azen SP; McCuen BW; Flynn HW; Lai MY; Ryan SJ
    Arch Ophthalmol; 1997 Mar; 115(3):335-44. PubMed ID: 9076205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 2.
    Arch Ophthalmol; 1992 Jun; 110(6):780-92. PubMed ID: 1596225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy. Silicone Study Report 3.
    McCuen BW; Azen SP; Stern W; Lai MY; Lean JS; Linton KL; Ryan SJ
    Retina; 1993; 13(4):279-84. PubMed ID: 8115726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of successful vitrectomy with silicone oil for advanced proliferative vitreoretinopathy.
    Sell CH; McCuen BW; Landers MB; Machemer R
    Am J Ophthalmol; 1987 Jan; 103(1):24-8. PubMed ID: 3799786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitrectomy and scleral buckling methods for proliferative vitreoretinopathy.
    Hanneken AM; Michels RG
    Ophthalmology; 1988 Jul; 95(7):865-9. PubMed ID: 3174035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perisilicone proliferation after vitrectomy for proliferative vitreoretinopathy.
    Lewis H; Burke JM; Abrams GW; Aaberg TM
    Ophthalmology; 1988 May; 95(5):583-91. PubMed ID: 3174019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relaxing retinotomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy. Silicone Study Report 5. The Silicone Study Group.
    Blumenkranz MS; Azen SP; Aaberg T; Boone DC; Lewis H; Radtke N; Ryan SJ
    Am J Ophthalmol; 1993 Nov; 116(5):557-64. PubMed ID: 8238214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daunomycin and silicone oil for the treatment of proliferative vitreoretinopathy.
    Wiedemann P; Leinung C; Hilgers RD; Heimann K
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(2):150-2. PubMed ID: 2044976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and control of proliferative vitreoretinopathy: primary retinal detachment surgery using silicone oil as a planned two-stage procedure in high-risk cases.
    Alexander P; Prasad R; Ang A; Poulson AV; Scott JD; Snead MP
    Eye (Lond); 2008 Jun; 22(6):815-8. PubMed ID: 17277751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inferior retinotomy and silicone oil tamponade for recurrent inferior retinal detachment and grade C PVR in eyes previously treated with pars plana vitrectomy or scleral buckle.
    Mancino R; Aiello F; Ciuffoletti E; Di Carlo E; Cerulli A; Nucci C
    BMC Ophthalmol; 2015 Dec; 15():173. PubMed ID: 26645589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anterior proliferative vitreoretinopathy in the silicone study. Silicone Study Report Number 10.
    Diddie KR; Azen SP; Freeman HM; Boone DC; Aaberg TM; Lewis H; Radtke ND; Ryan SJ
    Ophthalmology; 1996 Jul; 103(7):1092-9. PubMed ID: 8684799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Problems and timing in the removal of silicone oil.
    Kampik A; Höing C; Heidenkummer HP
    Retina; 1992; 12(3 Suppl):S11-6. PubMed ID: 1455076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of silicone oil removal in advanced proliferative vitreoretinopathy.
    Zilis JD; McCuen BW; de Juan E; Stefansson E; Machemer R
    Am J Ophthalmol; 1989 Jul; 108(1):15-21. PubMed ID: 2665501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study.
    Scott IU; Flynn HW; Murray TG; Feuer WJ;
    Am J Ophthalmol; 2003 Sep; 136(3):454-63. PubMed ID: 12967798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term outcome after silicone oil removal].
    Pavlovic S; Dick B; Schmidt KG; Tomic Z; Latinovic S
    Ophthalmologe; 1995 Oct; 92(5):672-6. PubMed ID: 8750994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preservation of anterior capsule during vitrectomy and lensectomy for retinal detachment with proliferative vitreoretinopathy.
    MacCumber MW; Packo KH; Civantos JM; Greenberg JB
    Ophthalmology; 2002 Feb; 109(2):329-33. PubMed ID: 11825819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.